title: Beta-adrenergic antagonists in the treatment of glaucoma.
abstract: OBJECTIVE
  Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for glaucoma. Since the introduction of new molecules in clinical routine, the current role of beta-blockers in glaucoma therapy has been rediscussed. In particular, concerns have been raised regarding their actual safety profile.
  
  
  METHODS
  This review will focus on the latest advances on the efficacy and safety profiles of non-selective beta-blockers.
  
  
  CONCLUSIONS
  The data provided will help to trace a more appropriate role for beta-blockers in glaucoma therapy.
authors.affiliation: Glaucoma Research and Care Center, University of Parma, Italy. s.gandolfi@rsadvnet.it
authors.forename: S A
authors.initials: SA
authors.lastname: Gandolfi
authors.forename: L
authors.initials: L
authors.lastname: Cimino
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D012449:Safety
chemical_list: D000319:Adrenergic beta-Antagonists